Background: Laboratory and some epidemiological reported an inverse association with vitamin C intake. studies suggest that antioxidants, such as vitamin C,
Introduction

Materials and methods
Laboratory studies and animal experiments suggest
We sought to include all relevant reports (including that oxidative modification of low density lipoproabstracts) of cross-sectional studies, prospective tein (LDL)-cholesterol plays an important role in the studies and trials in humans that examined the early development of atherosclerotic lesions. 1, 2 This association between vitamin C and BP. suggestion has prompted examination of the We concluded observational studies that measrelationship between intake of dietary antioxidants, ured either intake of vitamin C or plasma vitamin C such as vitamin C, and cardiovascular disease. levels. We excluded therefore studies that reported Although several observational studies in humans their results in terms of foods and BP even if these have reported a protective association for stroke and foods were rich sources of vitamin C. We included heart attack with increased intake of vitamin C, 3-5 a only trials of vitamin C alone and excluded trials of recent systematic review concluded that overall the a combination of micro nutrients 14, 15 and trials of evidence is not persuasive. 6 dietary change, even if the result (among others) was A putative protective effect of vitamin C on carto increase the vitamin C intake by dietary means.
16 diovascular disease could be mediated through an These studies were excluded as it would be imposseffect on blood pressure (BP), 7 or an effect on lipids, 8 ible to estimate the effect of vitamin C alone. platelets 9,10 or haemostatic factors. 11 A number of Where several reports were made by the same studies and review articles 8,12,13 have examined the group on the same study, (for example see references hypothesis that vitamin C lowers BP but to our 17 and 18), the results from what was judged to be knowledge no systematic overview has been done. the definitive report, in this case reference 18, were This report aims to fill this gap in the literature.
selected. For the US NHANES I sample, two sets of analyses performed by different groups were included as they were considered to be substantially different, though the study was still only considered to have contributed one study population. 19, 20 where BP was treated as a continuous variable.
Five studies 19, 20, 28, 29, 31 reported on the association between vitamin C intake and BP in four popuReports that included data from more than one distinct population sample were allowed to contribute lations. Three of these five studies showed a significant inverse association between vitamin C and BP. more than one study population. 22 We searched MEDLINE and EMBASE The results of these observational studies are summarised in Table 1 . (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) using the search terms 'blood pressure' and 'ascorbic acid'. This was complemented by a Eleven studies 18, 22, [25] [26] [27] 30, [32] [33] [34] [35] [36] reported on the association between blood levels of vitamin C and search of personal bibliographic files, books and relevant reviews, 7,8,12,13 and follow-up of citations in BP in 14 populations. In 10 of these 14 populations a significant inverse association was reported, but in references already located. We continued the process of cross-referencing until no new references only four 27, [30] [31] [32] [33] [34] 36 was it possible to estimate directly the difference in BP for a 50 mol/L difference in were identified. These searches were not restricted to English language journals but all the articles plasma ascorbic acid. The observed difference for diastolic BP (DBP) ranged from −2.6 mm Hg to −9.4 located were written in English. The relevant information was extracted on to a standard form (adapted mm Hg, and for systolic BP (SBP) ranged from −3.6 mm Hg to −17.8 mm Hg. The results of these obserfrom one used for a previous systematic review), 23 by two of the authors (ARN and DC). The inforvational studies are summarised in Table 2 .
One prospective study has reported on the associmation was cross-checked and any discrepancies or differences of opinion reconciled.
ation between vitamin C intake and BP. SBP was 2.0 mm Hg lower in those eating 125 mg of vitamin C The observed difference in BP in cross-sectional studies was calculated for a difference in vitamin C per day compared with those eating 75 mg per day after 10 years. 43 intake of 100 mg per day or in plasma concentration of 50 mol/L. Over a limited range of intakes, the Two uncontrolled trials showed an inverse relationship. 37, 38 The results of these uncontrolled relationship between intake and plasma levels is linear so that a difference in intake of 100 mg of vittrials are summarised in Table 3 . Four controlled trials [39] [40] [41] [42] have been reported. The amin C a day results in a difference in plasma level of roughly 50 mol/L. 24 first of these 39 was in 67 people but only the effect on the treatment arm has been reported. The In some studies the difference in BP was presented for tertiles or quartiles of vitamin C intake second 40 was in 20 people, including both borderline hypertensive and normotensive subjects; it or status. For these studies the difference in BP between the highest and lowest groupings was divshowed a reduction of systolic but not DBP. The third 41 was among 27 hypertensive patients; it was ided by the mean vitamin C value for the highest, less the mean for the lowest and then multiplied by difficult to interpret because of interaction between the crossover periods. The most recent trial 42 was either 50 for plasma or 100 for intake. Where the mean vitamin C values for the quartiles were not among 48 elderly hypertensive patients. It showed a non-significant reduction in both systolic and provided, or other arbitrary groupings were used, the difference observed between the groupings in DBP. The results of these randomised controlled trials are summarised in Table 4 . the study is presented along with a description of these groupings.
The confounders recorded in the results are those Discussion used to adjust the observed association between vitamin C and BP. We found a consistent cross-sectional association between lower BP and either higher intake of vitamin C or higher levels of plasma ascorbic acid,
Results
although the trials of vitamin C supplementation so far reported have generally been too small and too Sixteen observational studies [18] [19] [20] 22, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] and six trials, [37] [38] [39] [40] [41] [42] published between 1978 and 1996, were varied to provide confirmatory evidence for a causal relationship. located and fulfilled the inclusion criteria. These sixteen observational studies reported crossAs well as trials of vitamin C alone two trials of multivitamin supplementation have been reported. 14, 15 sectional analyses in 18 populations. In one, 80 anti-oxidant deficient men were given an sustained reduction of mean population DBP of 2 mm Hg is associated with 14% less stroke and 8% anti-oxidant cocktail, including 600 mg of vitamin C. The study found no effect.
14 A larger multivitless coronary heart disease. An effect on BP of this magnitude for a difference in vitamin C intake of amin trial carried out among over 3000 Chinese men and women with oesophageal dysplasia reported a 100 mg per day, the content of a medium sized orange (which contains just over 50 per 100 g), 51 is small but statistically significant fall in SBP after 6 years of follow-up. Though any one (or more) of the consistent with that observed in cross-sectional studies. biologically active substances contained in the multivitamin supplement, which included 180 mg In summary there is an apparent inverse association of vitamin C with BP which is reasonably conof vitamin C, could explain the effect, it is certainly consistent with the hypothesis that vitamin C sistent across different studies and populations, with a variety of study designs. Further crossreduces BP. 15 We were unable to arrive at a summary measure sectional studies are required that are able to control adequately for other dietary confounders. If an indeof the reported protective association between vitamin C and BP because of the failure of some studies pendent cross-sectional association exists, larger and longer term trials of vitamin C supplementation to describe null findings and because of the lack of detail on the reported association contained in will be required to establish whether or not the observed association with BP is causal. others. While the associations observed in studies are likely to underestimate the true underlying association because of the regression-dilution prob-able error. assium, magnesium, calcium and fibre; nevertheless, 
